Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004

Journal of Medical Virology

Volumn 79, Issue 12, 2007, Pages 1802-1810

  Baaten, G G G ^a,b,c   Sonder, G J B ^a,c   Dukers, N H T M ^a,b   Coutinho, R A ^a,d   Van Den Hoek, J A R ^a,b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c National Coordination Centre for Traveler's Health Advice LCR   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Prevention; Seroepidemiology; The Netherlands; Urban; Viral hepatitis

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; ETHNIC GROUP; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MOROCCO; NETHERLANDS; POPULATION RESEARCH; SEROPREVALENCE; SURINAME; TURKEY (REPUBLIC); URBAN POPULATION; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS C VIRUS;

EID: 35548945690     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21009     Document Type: Article

References (38)

1. Alter MJ. 2003. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 39:S64-S69.
2. Balogun MA, Ramsay ME, Hesketh LM, Andrews N, Osborne KP, Gay NJ, Morgan-Capner P. 2002. The prevalence of hepatitis C in England and Wales. J Infect 45:219-226.
3. Beutels M, Van Damme P, Vranckx R, Meheus A. 1998. The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastroenterol Belg 61:4-7.
4. Cesur S, Akin K, Dogaroglu I, Birengel S, Balik I. 2002. Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area. Mikrobiyol Bul 36:79-83.
5. Corona R, Stroffolini T, Giglio A, Cotichini R, Tosti ME, Prignano G, Di Carlo A, Maini A, Mele A. 1999. Lack of evidence for increased risk of hepatitis A infection in homosexual men. Epidemiol Infect 123:89-93.
6. Cotter SM, Sansom S, Long T, Koch E, Kellerman S, Smith F, Averhoff F, Bell BP. 2003. Outbreak of hepatitis A among men who have sex with men: Implications for hepatitis A vaccination strategies. J Infect Dis 187:1235-1240.
7. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H. 2003. Hepatitis C in the general adult population of Oslo: Prevalence and clinical spectrum. Scand J Gastroenterol 38:864-870.
8. Diamond C, Thiede H, Perdue T, Secura GM, Valleroy L, Mackellar D, Corey L. 2003. Viral hepatitis among young men who have sex with men: Prevalence of infection, risk behaviors, and vaccination. Sex Transm Dis 30:425-432.
9. Frösner GG, Papaevangelou G, Butler R, Iwarson S, Lindholm A, Courouce-Pauty A, Haas H, Deinhardt F. 1979. Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol 110:63-69.
10. Grosheide PM, Klokman-Houweling JM, Conyn-Van Spaendonck MA. 1995. Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in The Netherlands, 1989-92. National Hepatitis B Steering Committee. BMJ 311:1200-1202.
11. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. 2006. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 21:299-305.
12. Gust ID, Lehmann NI, Lucas CR. 1978. Relationship between prevalence of antibody to hepatitis A antigen and age: A cohort effect? J Infect Dis 138:425-426.
13. Health Council of the Netherlands. 2001. Universal vaccination against hepatitis B. The Hague: Health Council of the Netherlands. Publication no. 2001/03.
14. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11:97-107.
15. Martin A, Lemon SM. 2006. Hepatitis A virus: from discovery to vaccines. Hepatology 43:S164-S172.
16. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. 2005. Prevalence of hepatitis B infection in the southeastern region of Turkey: Comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis 58:15-19.
17. Nejmi S, Coursaget P, D'Khissy D, Barres JL, Chiron JP. 1984. Prevalence of infections caused by hepatitis A and B viruses in Morocco. Presse Med 13:1786-1787.
18. Prati D. 2006. Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review. J Hepatol 45:607-616.
19. Ross JD, Ghanem M, Tariq A, Gilleran G, Winter AJ. 2002. Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: A case control study of heterosexual and homosexual men. Sex Transm Infect 78:174-179.
20. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-567.
21. Sonder GJB, Van Steenbergen JE, Bovee LPMJ, Peerbooms PGH, Coutinho RA, Van den Hoek JAR. 2004. Hepatitis A virus immunity and seroconversion among contacts of acute hepatitis A patients in Amsterdam, 1996-2000: An evaluation of current prevention policy. Am J Public Health 94:1620-1626.
22. Termorshuizen F, Van de Laar MJ. 1998. The epidemiology of hepatitis A in the Netherlands, 1957-1998. Ned Tijdschr Geneeskd 142:2364-2368.
23. Termorshuizen F, Dorigo-Zetsma JW, De Melker HE, Van den Hof S, Conyn-Van Spaendonck MA. 2000. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: A population-based survey. Epidemiol Infect 124:459-466.
24. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. 2001. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 17:429-435.
25. Touzet S, Kraemer L, Colin C, Pradat P, Lanoir D, Bailly F, Coppola RC, Sauleda S, Thursz MR, Tillmann H, Alberti A, Braconier JH, Esteban JI, Hadziyannis SJ, Manns MP, Saracco G, Thomas HC, Trepo C. 2000. Epidemiology of hepatitis C virus infection in seven European Union countries: A critical analysis of the literature. HENCORE Group. Eur J Gastroenterol Hepatol 12:667-678.
26. Van de Laar TJ, Koppelman MH, Van der Bij AK, Zaaijer HL, Cuijpers HT, Van der Poel CL, Coutinho RA, Bruisten SM. 2006. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands. Transfusion 46:1719-1728.
27. Van den Hoek JAR, Van Haastrecht HJ, Goudsmit J, De Wolf F, Coutinho RA. 1990. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 162:823-826.
28. Van der Eerden LJ, Bosman A, van Duynhoven YT. 2004. Surveillance of hepatitis A in the Netherlands 1993-2002. Ned Tijdschr Geneeskd 148:1390-1394.
29. Van Gorkom J, Leentvaar-Kuijpers A, Kool JL, Coutinho RA. 1998. Annual epidemics of hepatitis A in four large cities related to holiday travel among immigrant children. Ned Tijdschr Geneeskd 142:1919-1923.
30. Van Houdt R, Sonder GJB, Dukers NHTM, Bovée LPMJ, Van den Hoek JAR, Coutinho RA, Bruisten SM. 2007. Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands. Vaccine 25:2698-2705.
31. Van Marrewijk CJ, Veldhuizen IK, Conyn-Van Spaendonck MAE, Kooy H, Van den Hof S, Dorigo-Zetsma JW. 1999. Prevalence of hepatitis B viral markers in the Dutch population: a population-based serosurveillance study (Pienter project). National Institute for Public Health and the Environment (NL). Report no. 243680001.
32. Van Steenbergen JE, Leentvaar-Kuijpers A, Baayen D, Dukers HT, Van Doornum GJ, Van den Hoek JA, Coutinho RA. 2002. Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998. Vaccine 20:7-11.
33. Van Steenbergen JE, Baayen D, Peerbooms PG, Coutinho RA, Van den Hoek A. 2004. Much gained by integrating contact tracing and vaccination in the hepatitis B antenatal screening program in Amsterdam, 1992-1999. J Hepatol 40:979-985.
34. Vancelik S, Guraksin A, Alp H. 2006. Hepatitis A seroepidemiology in Eastern Turkey. East Afr Med J 83:86-90.
35. Veldhuizen IK, Conyn-Van Spaendonck MAE, Dorigo-Zetsma JW. 1999. Seroprevalence of hepatitis B and C in the Dutch population. Infectieziektenbulletin 10:182-184.
36. Veldhuizen IK, Smits LJ, Van de Laar MJ. 2005. The importance of imported infections in maintaining hepatitis B in The Netherlands. Epidemiol Infect 133:113-119.
37. WHO. 2002. Global distribution of hepatitis A, B and C, 2001. Wkly Epidemiol Rec 77:45.
38. Zocchetti C, Consonni D, Bertazzi PA. 1997. Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int J Epidemiol 26:220-223.